Gene · 900
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Van der Waals Heterostructures-Recent Progress in Electrode Materials for Clean Energy Applications. | Materials (Basel) | 2021 | 34279324 | PubTator, text mining | PubMed |
| The Genomic Response to TGF-β1 Dictates Failed Repair and Progression of Fibrotic Disease in the Obstructed Kidney. | Front Cell Dev Biol | 2021 | 34277620 | PubTator, text mining | PubMed |
Tumor protein p53 mutation in archived tumor samples from a 12-year survivor of stage 4 pancreatic ductal adenocarcinoma may predict long-term survival with DeltaRex-G: A case report and literature review. | Mol Clin Oncol | 2021 | 34277005 | PubTator, text mining | PubMed |
| TCF11 Has a Potent Tumor-Repressing Effect Than Its Prototypic Nrf1α by Definition of Both Similar Yet Different Regulatory Profiles, With a Striking Disparity From Nrf2. | Front Oncol | 2021 | 34268128 | PubTator, text mining | PubMed |
| Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells. | Oncol Lett | 2021 | 34267814 | PubTator, text mining | PubMed |
| Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate? | Pathol Oncol Res | 2021 | 34257609 | PubTator, text mining | PubMed |
| Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies. | Trends Mol Med | 2021 | 34257007 | PubTator, text mining | PubMed |
| A ciliopathy complex builds distal appendages to initiate ciliogenesis. | J Cell Biol | 2021 | 34241634 | PubTator, text mining | PubMed |
| A Non-Coding RNA Network Involved in KSHV Tumorigenesis. | Front Oncol | 2021 | 34222014 | PubTator, text mining | PubMed |
| Analysis of Serum MicroRNA-122 Expression at Different Stages of Chronic Hepatitis B Virus Infection. | Biomed Res Int | 2021 | 34212044 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. | Cells | 2021 | 34202136 | PubTator, text mining | PubMed |
| National Trends in Cycling in Light of the Norwegian Bike Traffic Index. | Int J Environ Res Public Health | 2021 | 34201144 | PubTator, text mining | PubMed |
| The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies. | Front Mol Biosci | 2021 | 34195229 | PubTator, text mining | PubMed |
| SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome. | Nat Commun | 2021 | 34193871 | PubTator, text mining | PubMed |
| p53-intact cancers escape tumor suppression through loss of long noncoding RNA Dino. | Cell Rep | 2021 | 34192538 | PubTator, text mining | PubMed |
| Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs. | Mol Cell Proteomics | 2021 | 34186245 | PubTator, text mining | PubMed |
| Molecular mechanisms in Alzheimer's disease and the impact of physical exercise with advancements in therapeutic approaches. | AIMS Neurosci | 2021 | 34183987 | PubTator, text mining | PubMed |
| TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. | Cell Death Differ | 2021 | 34175897 | PubTator, text mining | PubMed |
| Redesigning donor-acceptor Stenhouse adduct photoswitches through a joint experimental and computational study. | Chem Sci | 2021 | 34164058 | PubTator, text mining | PubMed |
| Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. | World J Gastroenterol | 2021 | 34163105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/900/papers?page=24